Document Type : Original Article(s)


1 Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran

2 Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Professor, Department of Biostatistics and Epidemiology, Hypertension Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Interventional Cardiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

5 Instructor, Department of Critical Care Nursing, Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran

6 Professor, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran


BACKGROUND: Pre-hypertension (HTN) and HTN are risk factors for cardiovascular disease (CVD). Despite its importance, HTN is often underestimated and undiagnosed, especially in women. This study was designed to determine the prevalence of pre-HTN and HTN among a large sample of Iranian menopausal women.METHODS: This repeated cross-sectional study was conducted on 1013 menopausal women aged 41 to 85 years in Isfahan, Iran, in the years 2001, 2007, and 2016. The participants were selected through multistage cluster random sampling. Awareness, treatment, and control of HTN were assessed using a validated researcher-made questionnaire. Blood pressure was determined via an arm digital blood pressure monitor.RESULTS: The prevalence of HTN in the years 2001, 2007, and 2016 was 52.6%, 49.0%, and 51.6%, respectively; no significant changes were observed (P > 0.05). The prevalence of pre-HTN in these years was 56.6%, 53.3%, and 42.2%, respectively. In 2001 and 2007, respectively, 28.8% and 50.4% of menopausal women had HTN controlled by medication, and in 2016, 86.6% of women were aware of their disease and 62% of them had controlled HTN (P < 0.001).CONCLUSION: The results showed that HTN and pre-HTN were highly prevalent among Iranian menopausal women and markedly increased with age. Interventional population-based approaches are needed to improve knowledge and efficient practice that may help to lower the risk of HTN and CVD in this at-risk population.


  1. Li H, Yan X, Deng X, Yang L, Zhao S, Zou J, et al. A cross-sectional study of the prevalence, awareness, treatment and control of hypertension in Shenzhen, China. BMJ Open 2017; 7(6): e015206.
  2. Kim SJ, Lee J, Nam CM, Jee SH, Park IS, Lee KJ, et al. Progression rate from new-onset pre-hypertension to hypertension in Korean adults. Circ J 2011; 75(1): 135-40.
  3. Ferguson TS, Younger NO, Tulloch-Reid MK, Wright MB, Ward EM, Ashley DE, et al. Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: Analysis from a cross-sectional survey. BMC Cardiovasc Disord 2008; 8: 20.
  4. Engberding N, Wenger NK. Management of hypertension in women. Hypertens Res 2012; 35(3): 251-60.
  5. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016 update: A report from the American heart association. Circulation 2016; 133(4): e38-360.
  6. Rubinstein H. The meanings of menopause: Identifying the bio-psycho-social predictors of the propensity for treatment at menopause [Thesis]. Cambridge, UK: University of Cambridge; 2013.
  7. Nuzzo A, Rossi R, Modena MG. Hypertension alone or related to the metabolic syndrome in postmenopausal women. Expert Rev Cardiovasc Ther 2010; 8(11): 1541-8.
  8. Zambrana RE, Lopez L, Dinwiddie GY, Ray RM, Phillips LS, Trevisan M, et al. Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: Results from the Women's Health Initiative. Am J Hypertens 2014; 27(3): 372-81.
  9. Speroff L, Fritz M, Fritz MA. Clinical gynecologic endocrinology and infertility. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
  10. Hoffman BL. Williams ginecologia. New York, NY: McGraw-Hill Interamericana; 2017.
  11. Ahmad A, Oparil S. Hypertension in women: Recent advances and lingering questions. Hypertension 2017; 70(1): 19-26.
  12. Mojahedi MJ, Hami M, Shakeri MT, Hasani MH, Ahadi M. The Prevalence and related risk factors of hypertension in young adults in Mashhad Hypertension in young adults. Med J Mashad Univ Med Sci 2015; 58(5): 252-7. [In Persian].
  13. Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: A cross-sectional study in Iran. Epidemiol Health 2018; 40: e2018020.
  14. Mirzaei M, Mirzaei M, Bagheri B, Dehghani A. Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health 2020; 20(1): 667.
  15. Khajedaluee M, Hassannia T, Rezaee A, Ziadi M, Dadgarmoghaddam M. The prevalence of hypertension and its relationship with demographic factors, biochemical, and anthropometric indicators: A population-based study. ARYA Atheroscler 2016; 12(6): 259-65.
  16. Salem K, Kinsara AJ. Hypertension in low and middle-income countries: Challenges, gaps and limited resources specific strategies. World J Hypertens 2017; 7(1): 19-23.
  17. Eghbali-Babadi M, Khosravi A, Feizi A, Sarrafzadegan N. Design and implementation of a combined observational and interventional study: Trends of prevalence, awareness, treatment and control hypertension and the effect of expanded chronic care model on control, treatment and self-care. ARYA Atheroscler 2017; 13(5): 211-20.
  18. Jokar F, Yousefi H, Yousefy A, Sadeghi M. Begin again and continue with life: A qualitative study on the experiences of cardiac rehabilitation patients. J Nurs Res 2017; 25(5): 344-52.
  19. Khosravi A, Mehr GK, Kelishadi R, Shirani S, Gharipour M, Tavassoli A, et al. The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: Experiences from the Isfahan healthy heart program. BMC Cardiovasc Disord 2010; 10: 61.
  20. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens 2015; 29(4): 247-53.
  21. Najafipour H, Nasri HR, Rostamzadeh F, Amirzadeh R, Shadkam M, Mirzazadeh A. Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: Findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS). J Hum Hypertens 2020.
  22. Geldsetzer P, Manne-Goehler J, Theilmann M, Davies JI, Awasthi A, Vollmer S, et al. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults. JAMA Intern Med 2018; 178(3): 363-72.
  23. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: A meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep 2019; 21(4): 27.
  24. Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2013; 29(5): 528-42.
  25. Golshiri P, Akbari M, Abdollahzadeh MR. Age at natural menopause and related factors in Isfahan, Iran. J Menopausal Med 2016; 22(2): 87-93.
  26. Zhou B, Hajifathalian K, Lu Y, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387(10027): 1513-30.
  27. Meng XJ, Dong GH, Wang D, Liu MM, Liu YQ, Zhao Y, et al. Epidemiology of prehypertension and associated risk factors in urban adults from 33 communities in China-the CHPSNE study. Circ J 2012; 76(4): 900-6.
  28. Zhou Y, Zhou X, Guo X, Sun G, Li Z, Zheng L, et al. Prevalence and risk factors of hypertension among pre-and post-menopausal women: A cross-sectional study in a rural area of northeast China. Maturitas 2015; 80(3): 282-7.
  29. Chazova IE, Zhernakova I, Oshchepkova EV, Shal'nova SA, Iarovaia EB, Konradi AO, et al. Prevalence of cardiiovascular risk factors in Russian population of patients with arterial hypertension. Kardiologiia 2014; 54(10): 4-12.
  30. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012; 60(7): 599-606.
  31. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389(10064): 37-55.
  32. Agheli N, Assefzadeh S, Rajabi M, Ghoddousi A. Study of calories and macronutrients intake in people of Rasht and Qazvin. Journal of Inflammatory Diseases 2006; 10(1): 24-30. [In Persian].
  33. Motlagh Z, Mazloomy S, Mozaffari Khosravi H, Morowatisharifabad M, Askarshahi M. Salt intake among women refer to medical health centers, Yazd, Iran, 2011. J Shaheed Sadoughi Univ Med Sci 2011; 19(4): 550-60. [In Persian].
  34. Zilberman JM, Cerezo GH, Del Sueldo M, Fernandez-Perez C, Martell-Claros N, Vicario A. Association between hypertension, menopause, and cognition in women. J Clin Hypertens (Greenwich) 2015; 17(12): 970-6.
  35. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011; 183(9): 1007-13.
  36. Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens 2013; 31(7): 1364-71.
  37. Sabouhi F, Babaee S, Naji H, Zadeh AH. Knowledge, awareness, attitudes and practice about hypertension in hypertensive patients referring to public health care centers in Khoor & Biabanak. Iran J Nurs Midwifery Res 2011; 16(1): 34-40.